Emmaus Life Sciences Inc (PK:EMMA)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for EMMA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET October 31st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Oct 16/20 Oct 14/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 1,000 $0.830
Oct 15/20 Oct 14/20 Lee Willis C Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 1,600 $0.830
Oct 15/20 Oct 13/20 Lee Willis C Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 6,000 $0.840
Oct 13/20 Oct 13/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 3,000 $0.860
Oct 13/20 Oct 12/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 1,000 $0.900
Oct 13/20 Oct 9/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 500 $0.980
Oct 9/20 Oct 8/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 500 $1.00
Oct 9/20 Oct 7/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 1,000 $1.03
Oct 7/20 Oct 6/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 2,000 $0.920
Oct 7/20 Oct 5/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 1,250 $0.960
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for EMMA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET October 31st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Oct 16/20 Oct 14/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 1,000 $0.830
Oct 15/20 Oct 14/20 Lee Willis C Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 1,600 $0.830
Oct 15/20 Oct 13/20 Lee Willis C Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 6,000 $0.840
Oct 13/20 Oct 13/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 3,000 $0.860
Oct 13/20 Oct 12/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 1,000 $0.900
Oct 13/20 Oct 9/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 500 $0.980
Oct 9/20 Oct 8/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 500 $1.00
Oct 9/20 Oct 7/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 1,000 $1.03
Oct 7/20 Oct 6/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 2,000 $0.920
Oct 7/20 Oct 5/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 1,250 $0.960
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $EMMA

Competitors

Competitors with Recent Insider Filings
Moderna (OQ:MRNA)
Medpace Holdings (OQ:MEDP)
Forma Therapeutics Holdin (OQ:FMTX)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.